Literature DB >> 25971971

Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Tara C Tassin1, David R Benavides2, Florian Plattner1, Akinori Nishi3, James A Bibb4.   

Abstract

Metabotropic (slow) and ionotropic (fast) neurotransmission are integrated by intracellular signal transduction mechanisms involving protein phosphorylation/dephosphorylation to achieve experience-dependent alterations in brain circuitry. ERK is an important effector of both slow and fast forms of neurotransmission and has been implicated in normal brain function and CNS diseases. Here we characterize phosphorylation of the ERK-activating protein kinase MEK1 by Cdk5, ERK, and Cdk1 in vitro in intact mouse brain tissue and in the context of an animal behavioral paradigm of stress. Cdk5 only phosphorylates Thr-292, whereas ERK and Cdk1 phosphorylate both Thr-292 and Thr-286 MEK1. These sites interact in a kinase-specific manner and inhibit the ability of MEK1 to activate ERK. Thr-292 and Thr-286 MEK1 are phosphorylated in most mouse brain regions to stoichiometries of ~5% or less. Phosphorylation of Thr-292 MEK1 is regulated by cAMP-dependent signaling in mouse striatum in a manner consistent with negative feedback inhibition in response to ERK activation. Protein phosphatase 1 and 2A contribute to the maintenance of the basal phosphorylation state of both Thr-292 and Thr-286 MEK1 and that of ERK. Activation of the NMDA class of ionotropic glutamate receptors reduces inhibitory MEK1 phosphorylation, whereas forced swim, a paradigm of acute stress, attenuates Thr-292 MEK1 phosphorylation. Together, the data indicate that these inhibitory MEK1 sites phosphorylated by Cdk5 and ERK1 serve as mechanistic points of convergence for the regulation of ERK signaling by both slow and fast neurotransmission.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cdk5; ERK; MAPK; MEK1; NMDA receptor (NMDAR); cyclin-dependent kinase (CDK); depression; dopamine; phosphorylation; striatum

Mesh:

Substances:

Year:  2015        PMID: 25971971      PMCID: PMC4481230          DOI: 10.1074/jbc.M115.654897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase.

Authors:  G E Schafe; N V Nadel; G M Sullivan; A Harris; J E LeDoux
Journal:  Learn Mem       Date:  1999 Mar-Apr       Impact factor: 2.460

3.  Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.

Authors:  Hey-Kyoung Lee; Kogo Takamiya; Jung-Soo Han; Hengye Man; Chong-Hyun Kim; Gavin Rumbaugh; Sandy Yu; Lin Ding; Chun He; Ronald S Petralia; Robert J Wenthold; Michela Gallagher; Richard L Huganir
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

4.  Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory.

Authors:  E Y Yuen; W Liu; I N Karatsoreos; Y Ren; J Feng; B S McEwen; Z Yan
Journal:  Mol Psychiatry       Date:  2010-05-11       Impact factor: 15.992

5.  A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Authors:  Catharine H Duman; Lee Schlesinger; Masafumi Kodama; David S Russell; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

6.  Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons.

Authors:  A Nishi; G L Snyder; A C Nairn; P Greengard
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

7.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

Review 8.  Cognition enhancement strategies.

Authors:  James A Bibb; Mark R Mayford; Joe Z Tsien; Cristina M Alberini
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

9.  The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

Authors:  Haim Einat; Peixiong Yuan; Todd D Gould; Jianling Li; JianHua Du; Lei Zhang; Husseini K Manji; Guang Chen
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

10.  Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1).

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

View more
  6 in total

1.  The Crucial Role of Cyclin-Dependent Kinase-5-Ataxia-Telangiectasia Mutated Axis in ICH-Induced Neuronal Injury of Rat Model.

Authors:  Jing Wu; Xin Zhang; Yi Yan; Zhaohua Tang; Xiaochuan Sun; Gang Huo; Zhengbu Liao
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

2.  Disc1 Carrier Mice Exhibit Alterations in Neural pIGF-1Rβ and Related Kinase Expression.

Authors:  Razia Sultana; Amita Shrestha; Charles C Lee; Olalekan M Ogundele
Journal:  Front Cell Neurosci       Date:  2020-05-05       Impact factor: 5.505

3.  An ultrasensitive fiveplex activity assay for cellular kinases.

Authors:  Christian M Smolko; Kevin A Janes
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

4.  CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.

Authors:  Xiaoyan Bai; Xiaoyan Hou; Jianwei Tian; Jian Geng; Xiao Li
Journal:  Oncotarget       Date:  2016-06-14

5.  Detection of the Cell Cycle-Regulated Negative Feedback Phosphorylation of Mitogen-Activated Protein Kinases in Breast Carcinoma using Nanofluidic Proteomics.

Authors:  Yasuyo Urasaki; Ronald R Fiscus; Thuc T Le
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

Review 6.  Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.

Authors:  Ufuk Degirmenci; Mei Wang; Jiancheng Hu
Journal:  Cells       Date:  2020-01-13       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.